Psychedelic drugs such as psilocybin, used in combination with talking therapy, are opening new avenues of possibility within mental health care by offering a very different mechanism of treatment from existing psychiatric medications. The Multidisciplinary Association for Psychedelic Studies (MAPS) says that what really works is therapy enhanced by the drug. An upcoming trial aims to investigate the impact of talking therapy alongside two different doses of psilocybin inspired by the Perpetual Control Theory.  Source : MHT